IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring? - Petrova, L; Vrbacky, F; Lanska, M; Zavrelova, A; Zak, P; Hrochova, K (Clin Biochem, 2018)
[published correction appears in Clin Biochem. 2019 Jan;63:161]